5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[(1E)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-, (6R,7R)- (9CI)

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[(1E)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-, (6R,7R)- (9CI) 구조식 이미지
카스 번호:
104146-14-7
상품명:
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[(1E)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-, (6R,7R)- (9CI)
동의어(영문):
CBNumber:
CB010006896
분자식:
C19H18N6O5S3
포뮬러 무게:
506.58
MOL 파일:
104146-14-7.mol

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[(1E)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-, (6R,7R)- (9CI) 속성

밀도
1.75±0.1 g/cm3(Predicted)
산도 계수 (pKa)
2.43±0.50(Predicted)

안전

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[(1E)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-, (6R,7R)- (9CI) C화학적 특성, 용도, 생산

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[(1E)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-, (6R,7R)- (9CI) 준비 용품 및 원자재

원자재

준비 용품


5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[(1E)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-, (6R,7R)- (9CI) 공급 업체

글로벌( 3)공급 업체
공급자 전화 이메일 국가 제품 수 이점
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
Hubei Xinyang Medical Technology Co., Ltd 15347293736 15347293736
2853117764@qq.com China 8594 58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd 18162595016
3287908757@qq.com China 9887 58

5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-[(1E)-2-(4-methyl-5-thiazolyl)ethenyl]-8-oxo-, (6R,7R)- (9CI) 관련 검색:

Copyright 2019 © ChemicalBook. All rights reserved